Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 6/20 | 0.61 |
| ▸ | MAPT | P10636 | 7/20 | 0.57 |
| ▸ | APP | P05067 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4428107 | 0.84 | METAP1 (0.80) | METAP1MAPTCA12CA1CA2 | |
| SCHEMBL28680183 | 0.79 | METAP1 (0.67) | METAP1MAPTCA12CA1CA2 | |
| SCHEMBL14033557 | 0.79 | METAP1 (0.71) | METAP1MAPTCA12CA1CA2 | |
| SCHEMBL13039183 | 0.78 | APP (0.67) | MAPTAPPALDH1A1KMT2AMEN1 | |
| SCHEMBL31406586 | 0.76 | GSK3B (0.70) | METAP1MAPTCA12CA1CA2 | |
| SCHEMBL21779711 | 0.76 | METAP1 (0.67) | METAP1MAPTCA12CA1CA2 | |
| SCHEMBL8083180 | 0.76 | METAP1 (0.67) | METAP1MAPTCA12CA1CA2 | |
| SCHEMBL16543019 | 0.76 | METAP1 (1.00) | METAP1MAPTCA12CA1CA2 | |
| SCHEMBL13848414 | 0.76 | METAP1 (1.00) | METAP1MAPTCA12CA1CA2 | |
| SCHEMBL4096609 | 0.75 | METAP1 (1.00) | METAP1MAPTAPPCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12319661-B2 | Polycyclic compound | EUTEC NEW MATERIALS TECHNOLOGY (SUZHOU) CO., LTD. (CN) | 2025-06-03 | — | — | US | disclosed |
| CN-115745970-B | Polycyclic compound, preparation method and membrane | 江苏裕事达新材料科技有限责任公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-111285853-B | Polycyclic compound | 江苏裕事达新材料科技有限责任公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-115745970-A | Polycyclic compound, preparation method and film | 江苏裕事达新材料科技有限责任公司 | 2023-03-07 | — | — | CN | disclosed |
| US-20220017474-A1 | Novel Polycyclic Compound | EUTEC NEW MATERIALS TECHNOLOGY (SUZHOU) CO., LTD. (CN) | 2022-01-20 | — | — | US | disclosed |
| EP-3896067-A1 | NOVEL POLYCYCLIC COMPOUND | Eutec New Materials Technology (Suzhou) Co., Ltd (CN) | 2021-10-20 | — | — | EP | disclosed |
| WO-2020118933-A1 | NOVEL POLYCYCLIC COMPOUND | 优缔新材料科技(苏州)有限公司 | 2020-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12319661-B2 | Polycyclic compound | CUTA, CDH1, DSG1 | METAP1 4667/4885MAPT 187/4885APP 667/4885 |
| US-20220017474-A1 | Novel Polycyclic Compound | CUTA, DSG1, UACA | METAP1 4754/4885MAPT 295/4885APP 1095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.